Teva Pharmaceutical (TEVA) Reports In-Line Q2 EPS of $1.28

August 2, 2012 7:06 AM

Teva Pharmaceutical (NASDAQ: TEVA) reported Q2 EPS of $1.28 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found